Sabby Management, LLC Nektar Therapeutics Transaction History

Sabby Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$31.58 - $46.35 $2.49 Million - $3.66 Million	-78,915 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$30.43 - $56.65 $6.59 Million - $12.3 Million	-216,490 Reduced 73.29%	78,915 $2.59 Million
Q3 2018 Nov 14, 2018	BUY	$46.46 - $68.49 $2.48 Million - $3.66 Million	53,483 Added 22.11%	295,405 $18 Million
Q2 2018 Aug 14, 2018	BUY	$46.25 - $104.45 $8.47 Million - $19.1 Million	183,091 Added 311.22%	241,922 $11.8 Million
Q1 2018 May 15, 2018	BUY	$57.4 - $108.44 $2.23 Million - $4.21 Million	38,831 Added 194.16%	58,831 $6.25 Million
Q4 2017 Feb 14, 2018	BUY	$23.02 - $60.5 $460,400 - $1.21 Million	20,000	20,000 $1.19 Million

146

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $197M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.